Cellectar Biosciences' IPO

Cellectar Biosciences raised a round of funding on November 21, 2006. Investors include Public.

Cellectar Therapeutics, formerly Novelos Therapeutics, is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's no…

Articles about Cellectar Biosciences' IPO: